ResMed Inc. (RMD) reported third quarter adjusted EPS of $0.65 after the bell Thursday, which was in line with analysts' expectations. Revenue increased to $422.5 million from $397.8 million last year. Analysts expected revenue of $424.79 million.
ResMed gapped open sharply lower Friday morning and is now down 7.38 at $66.00 on above average volume. The stock has dropped to a month and a half low and has fallen below its 50-day moving average.
For comments and feedback contact: editorial@rttnews.com
Business News